Development asset linked to Edgewise Therapeutics in public FDA and regional records.
pharma · Becker Muscular Dystrophy · Muscular Dystrophies · EWTX
Edgewise Therapeutics
Edgewise Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
1715 38th St., Boulder, CO 80301, US HQ
2017 Founded
154 Employees
Public company Type
EWTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1715 38th St., Boulder, CO 80301, US
- Founded
- 2017
- Employees
- 154
- Programs
- 15
- Drugs
- 3
- Patents
- 7
Edgewise Therapeutics pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Edgewise Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Edgewise Therapeutics in public FDA and regional records.
-
Development asset linked to Edgewise Therapeutics in public FDA and regional records.